Terms: = Bone cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Prognosis
40 results:
1. Proteomic profiling of serum exosomes reveals acute phase response and promotion of inflammatory and platelet activation pathways in patients with heat stroke.
Li Y; Li H; Ma W; Maegele M; Tang Y; Gu Z
PeerJ; 2023; 11():e16590. PubMed ID: 38107577
[No Abstract] [Full Text] [Related]
2. Expression and Clinical Significance of Various Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy.
Xie L; Chen C; Liang X; Xu J; Sun X; Sun K; Yang R; Tang X; Guo W
Orthop Surg; 2023 Mar; 15(3):829-838. PubMed ID: 36519392
[TBL] [Abstract] [Full Text] [Related]
3. AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation.
Wei R; Zhu Y; Zhang Y; Zhao W; Yu X; Wang L; Gu C; Gu X; Yang Y
Cancer Commun (Lond); 2022 Nov; 42(11):1185-1206. PubMed ID: 36042007
[TBL] [Abstract] [Full Text] [Related]
4. A truncated derivative of fgfr1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML.
Cai B; Liu Y; Chong Y; Mori SF; Matsunaga A; Zhang H; Fang X; Chang CS; Cowell JK; Hu T
Mol Cancer; 2022 Jul; 21(1):156. PubMed ID: 35906694
[TBL] [Abstract] [Full Text] [Related]
5. H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.
Al Sharie S; Talafha M; Abu Laban D; Al Awabdeh T; Al-Mousa A; Al-Masri N; Al-Hussaini M
Clin Neuropathol; 2022; 41(6):263-270. PubMed ID: 35770519
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma.
Herviou L; Ovejero S; Izard F; Karmous-Gadacha O; Gourzones C; Bellanger C; De Smedt E; Ma A; Vincent L; Cartron G; Jin J; De Bruyne E; Grimaud C; Julien E; Moreaux J
Clin Epigenetics; 2021 Sep; 13(1):174. PubMed ID: 34530900
[TBL] [Abstract] [Full Text] [Related]
7. Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.
Whittle SB; Offer K; Roberts RD; LeBlanc A; London C; Majzner RG; Huang AY; Houghton P; Alejandro Sweet Cordero E; Grohar PJ; Isakoff M; Bishop MW; Stewart E; Slotkin EK; Greengard E; Borinstein SC; Navid F; Gorlick R; Janeway KA; Reed DR; Hingorani P
Pediatr Blood Cancer; 2021 Sep; 68(9):e29188. PubMed ID: 34137164
[TBL] [Abstract] [Full Text] [Related]
8. The dark side of histones: genomic organization and role of oncohistones in cancer.
Amatori S; Tavolaro S; Gambardella S; Fanelli M
Clin Epigenetics; 2021 Apr; 13(1):71. PubMed ID: 33827674
[TBL] [Abstract] [Full Text] [Related]
9. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
[TBL] [Abstract] [Full Text] [Related]
10. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
Helbig G; Klion AD
Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical Significance of fgfr1 Gene Abnormalities in Blood Tumors].
Zhang CL; Tang GS; Guo MQ; Cheng H; Liu MD; Yang JM; Gong SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):983-988. PubMed ID: 32552969
[TBL] [Abstract] [Full Text] [Related]
12. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
13. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).
Kanchan RK; Perumal N; Atri P; Chirravuri Venkata R; Thapa I; Klinkebiel DL; Donson AM; Perry D; Punsoni M; Talmon GA; Coulter DW; Boue' DR; Snuderl M; Nasser MW; Batra SK; Vibhakar R; Mahapatra S
Brain Pathol; 2020 Jul; 30(4):732-745. PubMed ID: 32145124
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
Inkol JM; Poon AC; Mutsaers AJ
Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
[TBL] [Abstract] [Full Text] [Related]
15. [Myeloid/lymphoid neoplasms with eosinophilia and fgfr1 rearrangement: 5 cases report and literatures review].
Liu YT; Zhao JW; Feng J; Li QH; Chen YM; Qiu LG; Xiao ZJ; Li Y; Gong BF; Gong XY; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):848-852. PubMed ID: 31775485
[No Abstract] [Full Text] [Related]
16. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
[TBL] [Abstract] [Full Text] [Related]
17. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-fgfr1 gene fusion.
Saba KH; Cornmark L; Rissler M; Fioretos T; Åström K; Haglund F; Rosenberg AE; Brosjö O; Nord KH
Genes Chromosomes Cancer; 2019 Oct; 58(10):731-736. PubMed ID: 31066955
[TBL] [Abstract] [Full Text] [Related]
18. B7-H3 and its role in bone cancers.
He L; Li Z
Pathol Res Pract; 2019 Jun; 215(6):152420. PubMed ID: 31060912
[TBL] [Abstract] [Full Text] [Related]
19. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
[TBL] [Abstract] [Full Text] [Related]
20. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Smeland S; Bielack SS; Whelan J; Bernstein M; Hogendoorn P; Krailo MD; Gorlick R; Janeway KA; Ingleby FC; Anninga J; Antal I; Arndt C; Brown KLB; Butterfass-Bahloul T; Calaminus G; Capra M; Dhooge C; Eriksson M; Flanagan AM; Friedel G; Gebhardt MC; Gelderblom H; Goldsby R; Grier HE; Grimer R; Hawkins DS; Hecker-Nolting S; Sundby Hall K; Isakoff MS; Jovic G; Kühne T; Kager L; von Kalle T; Kabickova E; Lang S; Lau CC; Leavey PJ; Lessnick SL; Mascarenhas L; Mayer-Steinacker R; Meyers PA; Nagarajan R; Randall RL; Reichardt P; Renard M; Rechnitzer C; Schwartz CL; Strauss S; Teot L; Timmermann B; Sydes MR; Marina N
Eur J Cancer; 2019 Mar; 109():36-50. PubMed ID: 30685685
[TBL] [Abstract] [Full Text] [Related]
[Next]
